Skip to main content
OpenTrials

Clinical trial condition

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

Explore clinical trials studying Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma trial results

Recruiting

A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma

NCT07023315

Conditions
Adenocarcinoma, Carcinoma, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, +3 more
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
View Trial Details
Recruiting

Pan-tumor MRD Study

NCT06605404

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Medical Oncology Associates of San Diego San Diego, California, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
View Trial Details
Active, Not Recruiting

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

NCT04208347

Conditions
Adenocarcinoma, Carcinoma, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, +3 more
Locations
  • Affiliated Hospital of Hebei University Baoding, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Xiangya Hospital Central South University Changsha, China
  • Heping Hospital Affiliated to Changzhi Medical College Changzhi, China
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details

Related conditions